Introduction {#s1}
============

Several reports have demonstrated that directed differentiation of human pluripotent stem cells (hPSCs), which include embryonic (hESCs) and induced (iPSCs) stem cells, is one of the most efficient approaches to achieving differentiation of a cell or tissue of interest ([@bib16]; [@bib37]; [@bib70]; [@bib72]; [@bib87]). Using this approach, differentiation of hPSCs into lung lineages has been achieved using diverse methodology with varying degrees of success ([@bib34]; [@bib44]; [@bib55]; [@bib87]; [@bib26]; [@bib32]; [@bib24]).

Thus far, the majority of efforts to differentiate lung lineages from hPSCs have focused on using 2-dimensional (2D) monolayer cultures. Several recent advances in generating 3-dimensional (3D) organ-like tissues, called 'organoids', have been reported ([@bib49]; [@bib72]; [@bib57]; [@bib76]; [@bib39]; [@bib48]). Such 3D models offer several advantages; they often possess structural organization similar to the native organ, cell types from multiple germ layers (for example, mesoderm and endoderm ([@bib72]; [@bib48]; [@bib85]), and multiple cellular lineages, making them a physiologically complex model to study developmental processes, tissue homeostasis and pathological conditions in vitro.

Previous work has demonstrated that activation of FGF and WNT signaling synergistically drives CDX2+ intestinal lineage commitment in hPSC-derived endoderm and also drives 'morphogenesis in a dish', where the 2D tissues self-organize into 3D spheroids comprised of mesenchymal and polarized epithelial layers that detach from the adherent cell layer ([@bib72]). It has also been demonstrated that inhibition of BMP and TGFβ signaling is able to drive tissue into a SOX2+ foregut lineage ([@bib27]; [@bib48]). Building on these previous studies, we show that simultaneous stimulation of WNT and FGF signaling while inhibiting BMP/TGFβ signaling pathways in hPSC-derived endoderm cultures prevents intestinal lineage commitment, and instead, favors a SOX2+ anterior foregut fate while also robustly generating SOX2+ anterior foregut 3D spheroid structures.

In order to further restrict foregut spheroids to the lung lineage, the current study focused on manipulating FGF and HH signaling. In the mouse, high levels of Fgf signaling have been shown to induce Shh expression in the lung endoderm ([@bib29]; [@bib53]; [@bib63]) which is accompanied by induction of the Nkx2.1+ lung progenitor field ([@bib29]; [@bib69]). Shh then signals from the endoderm to the mesoderm, and mutations in *Shh, Gli2* or *Gli3* lead to perturbed lung development, with *Gli2/Gli3* double knockout mice showing lung agenesis ([@bib4]; [@bib54]; [@bib42]). Our results demonstrate that FGF2 induces NKX2.1, PAX8, and SHH in human foregut endoderm cultures. By using pharmacological inhibitors of FGF and HH signaling we demonstrate that SHH is required for NKX2.1 expression downstream of FGF2, and that FGF2 also induces PAX8 independently of HH signaling. These observations suggest a paradigm where FGF^Lo^/HH^Hi^ conditions preferentially induce PAX8^Lo^/NKX2.1^Hi^ lung progenitors and FGF^Hi^/HH^Lo^ conditions favor a PAX8^Hi^/NKX2.1^Lo^ fate. Given that Pax8 is required for thyroid development, we focused on defining the most robust conditions to induce NKX2.1 while minimizing PAX8 expression ([@bib36]; [@bib46]; [@bib89]; [@bib79]; [@bib42]; [@bib38]; [@bib10]; [@bib58]). By applying HH^Hi^ conditions during generation of foregut spheroids we were able to enhance NKX2.1 expression in foregut spheroids and subsequently expand spheroids in media containing FGF10, allowing them to grow into organoids. Organoids persisted in culture for over 100 days and developed well-organized proximal-like airway epithelial structures that included many cell types found in the proximal lung epithelium, including basal and ciliated cells along with rare club cells. Moreover, proximal airway structures were often surrounded by smooth muscle actin (SMA) positive mesenchymal tissue. Organoids also possessed distal-like epithelial cells that co-expressed progenitor markers, SFTPC/SOX9 and HOPX/SOX9, consistent with early bipotent alveolar progenitor cells seen in mice ([@bib20]; [@bib78]). To support the idea that organoids may be more similar to a developing lung with abundant progenitor cells, we used RNA-sequencing to compare the global transcriptional profile of organoids to the human fetal and adult lung, undifferentiated hESCs and definitive endoderm. Principal component analysis, hierarchical clustering and Spearman\'s correlation all show that organoids have striking similarity to the human fetal lung.

Taken together, our data demonstrates an efficient and robust in vitro system to generate complex, 3D human lung organoids that are immature/fetal in nature. We anticipate that this model will serve as an unparalleled model for the study of human lung development, maturation and disease.

Results {#s2}
=======

Differentiation of hPSCs into anterior foregut spheroids {#s2-1}
--------------------------------------------------------

We and others have reported efficient induction of human endoderm using ActivinA ([@bib16]; [@bib90]; [@bib72]), and a further lineage restriction into SOX2+ anterior foregut endoderm using inhibition of BMP and TGFβ signaling ([@bib27]; [@bib43]). We have recently demonstrated that inhibition of BMP signaling during intestinal lineage induction with WNT and FGF ligands is sufficient to inhibit intestinal CDX2 and induce SOX2+ posterior foregut spheroids capable of giving rise to human gastric (antral) organoids ([@bib48]). Given that the lung is derived from the anterior foregut, we sought to define conditions to generate ventral anterior foregut spheroids. To do this, we tested if dual inhibition of BMP and TGFβ was able to anteriorize cultures, as previously described ([@bib27]). We treated hESCs with ActivinA (100 ng/ml) for 4 days to induce endoderm, followed by 4 days of Noggin (NOG, 200 ng/ml) and the small molecule TGFβ inhibitor, SB431542 (SB, 10 µM). We confirmed that these conditions were able to induce robust mRNA and protein expression of SOX2, which co-expressed the endodermal marker FOXA2, while repressing the intestinal lineage marker CDX2 ([Figure 1A--C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). QRT-PCR analysis also showed that compared to controls (in which endoderm was induced but was not exposed to NOG/SB), exposure to NOG/SB robustly induced ventral anterior foregut genes *NKX2.1* and *PAX8*, while the posterior foregut transcript, *PDX1* was reduced. *HHEX*, which is expressed in the developing liver, biliary system and thyroid, but is absent from the lung primordium, remained unchanged ([Figure 1B](#fig1){ref-type="fig"}). Given that NKX2.1 is expressed in the lung and thyroid primordium, and PAX8 is expressed in the thyroid primordium, these results suggest that 4 day ActivinA treatment followed by a 4 day NOG/SB treatment biases the cultures towards ventral-anterior foregut lineages.10.7554/eLife.05098.003Figure 1.Generation of three-dimensional ventral anterior foregut spheroids from endoderm monolayers.(**A**) hESCs were differentiated into foregut endoderm by treating cells with 4 days of Activin A (ACTA) followed by 4 days of NOG+SB. (**B**) Foregut endoderm (NOG+SB) had high expression of the foregut marker *SOX2* while the hindgut marker *CDX2* was significantly reduced compared to untreated endoderm controls (End). NOG+SB monolayers had high expression of ventral anterior foregut genes *NKX2.1* and *PAX8* while the posterior foregut marker *PDX1* was reduced. The foregut marker *HHEX* is expressed in the developing liver, biliary system, and thyroid and remained unchanged. (**C**) The majority of cells in NOG+SB treated cultures were SOX2 positive (green) compared to the control, in which only scattered clusters of cells were SOX2 positive. The scale bar represents 200 µm. (**D**) hESCs were differentiated into foregut spheroids by treating cells with 4 days of ACTA and then additional 4--6 days of NOG+SB+FGF4+Ch. Representative images of a spheroid in a matrigel droplet are shown as a whole mount image. Scale bar represents 100 µm. (**E**) Foregut spheroids (NOG+SB+FGF4+Ch) had high expression of the foregut marker *SOX2* while the hindgut marker *CDX2* was significantly reduced compared to untreated endoderm control (End) (top panel). Spheroids had high expression of anterior foregut genes *NKX2.1* and *PAX8* while the posterior foregut marker *PDX1* was reduced and HHEX was unchanged (bottom panel). \*p \< 0.05, error bars represent SEM. (**F**) The majority of cells in foregut spheroids are FOXA2+ (green, left panel) and SOX2+ (white, right panel) and ECAD+ (red, right panel). Scale bar represent 50 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.003](10.7554/eLife.05098.003)10.7554/eLife.05098.004Figure 1---figure supplement 1.Monolayer cultures express lung specific markers.Immunohistochemistry for markers expressed in endoderm, ventral foregut or lung epithelium were assessed (SOX2, FOXA2, NKX2.1, SOX9) in endoderm controls, foregut controls or foregut cultures treated with SAG or SAG+SU. (**A**) All conditions express endoderm marker FOXA2 (red), but the foregut (NOG+SB) control, SAG and SAG+SU treated cultures have co-expression of FOXA2 (red) and SOX2 (green) in the majority of cells. (**B**) All conditions expressed endoderm marker FOXA2 (red), but only foregut endoderm treated with SAG and SAG+SU have robust NKX2.1+ cells (green) that also express FOXA2 (red). (**A**--**B**) Scale bars represent 200 µm and apply to all images. (**C**) Only foregut endoderm treated with SAG and SAG+SU have robust NKX2.1+ cells (green) with the majority of cell co-expressing with lung epithelial marker SOX9 (red). Scale bar represents 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.004](10.7554/eLife.05098.004)10.7554/eLife.05098.005Figure 1---figure supplement 2.Foregut spheroids co-express endoderm and lung specific markers.(**A**) NOG/SB/FGF4/Ch spheroids have weak NKX2.1 (green) expression which co-expresses with endoderm marker FOXA2 (red). (**B**) The majority of cells in the spheroid express SOX2 (green) and co-stain with FOXA2 (red). Scale bars represent 50 µM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.005](10.7554/eLife.05098.005)10.7554/eLife.05098.006Figure 1---figure supplement 3.Foregut spheroids consist of both epithelial and mesenchymal cells.NOG/SB/FGF4/Ch spheroids have a minor population of Vimentin (VIM, white) positive mesenchymal cells, while the majority of cells are epithelial and express ECAD (red). Scale bar represents 50 µM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.006](10.7554/eLife.05098.006)10.7554/eLife.05098.007Figure 1---figure supplement 4.NOG+SB+FGF4+Ch spheroids do not express neural markers.hESCs were differentiated into endoderm by treating with 4 days of ActivinA (ACTA) and spheroids were generated with an additional 4 days of NOG+SB+FGF4+Ch. Neural cultures were not treated with ACTA, but were treated with NOG+SB for 8 days. Compared to foregut spheroids (NOG+SB+FGF4+Ch), NOG+SB neural cultures had a significant increase in neural markers *NESTIN*, *SOX1*, and *PAX6* and significant decrease in *FOXA2*, which is highly expressed in endoderm. \*p \< 0.05, error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.007](10.7554/eLife.05098.007)

Addition of FGF4 plus WNT3A (or Chir99021, a GSK3β inhibitor that enhances β-catenin dependent WNT signaling) promotes CDX2 intestinal lineage commitment and 3D spheroid formation in endoderm cultures ([@bib72]; [@bib88]; [@bib14]). Based on our results in [Figure 1B--C](#fig1){ref-type="fig"}, we hypothesized that combining FGF, Chir99021, NOG and SB would result in the generation of SOX2+ ventral-anterior foregut spheroids. To test this, we generated endoderm (4 days ACTA) and added no growth factors (Endoderm controls) or NOG, SB, FGF4, and Chir99021 (NOG/SB/F/Ch) ([Figure 1D](#fig1){ref-type="fig"}). Addition of all four factors resulted in the generation of 3-dimensional SOX2+, CDX2− spheroids ([Figure 1E,F](#fig1){ref-type="fig"}). SOX2+ spheroids also expressed the endodermal protein FOXA2, and were epithelial, co-expressing E-Cadherin (ECAD) ([Figure 1F](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). In addition to SOX2, spheroids exhibited higher mRNA expression of anterior foregut lineage markers *NKX2.1* and *PAX8* compared to endoderm controls, suggesting that they are ventral-anterior foregut spheroids ([Figure 1E](#fig1){ref-type="fig"}), however, immunofluorescence revealed that levels of NKX2.1 protein were just above the detection threshold ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Spheroids also possess a minor population of cells that are mesodermal in origin staining positive for Vimentin protein (VIM) ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Given that neural tissues also express NKX2.1, PAX8, SOX2, and FOXA2, and that neural induction protocols use dual BMP and TGFβ inhibition, we wanted to exclude the possibility that spheroids were neural in nature. To do this, we generated endoderm control cultures, foregut spheroids (ActivinA followed by NOG/SB/F/Ch), and induced neural tissue by adding NOG/SB to hESC cultures that were not treated with ActivinA ([@bib11]). By examining induction of the neural markers *NESTIN, SOX1,* and *PAX6*, we confirmed that these transcripts were highly induced in dual NOG/SB neural cultures, but were low in ventral foregut spheroid cultures. In contrast, *FOXA2*, which is expressed in the foregut ([@bib51]; [@bib3]; [@bib16], [@bib18]; [@bib37]; [@bib70]; [@bib19]) and in some neural tissues ([@bib70][@bib74]), had high expression in ventral foregut spheroids, but was significantly reduced in dual NOG/SB neural conditions ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Taken together, these results strongly suggest spheroids are indeed foregut, and not of neural origin.

Induction of anterior foregut endoderm into a lung lineage through modulation of FGF and HH signaling {#s2-2}
-----------------------------------------------------------------------------------------------------

Many signaling pathways are important for lung induction and development (reviewed in [@bib50]; [@bib83]; [@bib53]; [@bib63]). High levels of Fgf signaling have been shown to induce Shh and Nkx2.1 expression in the foregut endoderm in mice ([@bib29]; [@bib69]); furthermore, Gli2/3 null mouse embryos fail to form lungs ([@bib54]) and Hh signaling is important for lung mesenchyme proliferation in vivo ([@bib4]). These data confirm that Fgf and Hh signaling are critical for lung specification and ligands from both signaling pathways have been applied to hPSC derived lung lineages in 2D cultures ([@bib87]; [@bib32]). In our cultures we have reported that approximately 85--95% of cells are endoderm, but a portion of the remaining cells are mesodermal and this small mesodermal population is maintained in the spheroids and organoids ([@bib72]; [@bib48]) ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Therefore, based on mouse and hPSC studies, we hypothesized that FGF and/or HH signaling would induce an NKX2.1+ lung lineage in anterior foregut endoderm. To test our hypothesis we initially focused on adherent endoderm monolayer cultures to optimize induction conditions. Cultures were treated for 4 days with ActivinA followed by an additional 4 days with NOG/SB (referred to as Foregut). Controls consisted of ActivinA treatment only followed by no additional growth factors (Endoderm controls), or ActivinA followed by NOG/SB, followed by no additional factors (Foregut controls). All experimental groups were compared to both endoderm and foregut controls ([Figure 2](#fig2){ref-type="fig"}). We first tested the ability of FGF2 to induce *SHH*, *NKX2.1* and *PAX8* by exposing foregut cultures to low and high concentrations of FGF2 (50, 500 ng/ml) ([Figure 2A](#fig2){ref-type="fig"}). We observed a robust concentration dependent increase in *SHH* and *PAX8* mRNA expression compared to foregut or endoderm controls, and a modest increase of *NKX2.1* expression at the highest dose of FGF2 (500 ng/ml) ([Figure 2A](#fig2){ref-type="fig"}). We also observed that dual NOG/SB inhibition in endoderm cultures induced robust *NKX2.1* and *PAX8* expression without adding FGF2 ([Figures 1B, 2A](#fig1 fig2){ref-type="fig"}). Thus, we wanted to determine if *NKX2.1* expression in foregut cultures was due to endogenous FGF and/or HH signaling. To test this, we inhibited the FGF or HH pathway with small molecules SU5402 (SU, 10 µm) and Sant-2 (10 µm) respectively ([Figure 2B--C](#fig2){ref-type="fig"}). Treating foregut cultures with the FGF inhibitor SU caused a significant, robust reduction in *PAX8* and a modest reduction in *SHH*, while *NKX2.1* expression was unchanged compared to foregut controls ([Figure 2B](#fig2){ref-type="fig"}). Conversely, inhibition of HH signaling caused a significant reduction in *NKX2.1* expression, but not *PAX8* compared to untreated foregut*.* When FGF2 was added to the cultures, we observed a modest increase in *NKX2.1* expression, and when FGF was added along with Sant-2, *NKX2.1* expression was significantly reduced ([Figure 2C](#fig2){ref-type="fig"}). Together our results suggest a hierarchy where FGF is upstream of SHH and PAX8, and where SHH is upstream of NKX2.1. To test if HH signaling was able to induce NKX2.1 in foregut cultures, we added the Smoothened agonist, SAG (1 µM) to foregut cultures. The addition of SAG induced a 6.5-fold increase of *NKX2.1* expression above foregut controls ([Figure 2D](#fig2){ref-type="fig"}). However, SAG alone did not reduce *PAX8* expression.10.7554/eLife.05098.008Figure 2.Induction of NKX2.1 in anterior foregut endoderm by modulating FGF and HH signaling.(**A**) hESCs were differentiated into endoderm (End) or anterior foregut with NOG+SB (For). Anterior foregut was treated with low (50 ng/ml) and high (500 ng/ml) concentrations of FGF2. FGF2 caused a dose-dependent increase in *SHH* and *PAX8* expression with a modest increase in *NKX2.1* expression compared to untreated endoderm controls. Note that *NKX2.1* expression is increased by NOG+SB exposure alone (no FGF2). (**B**) Addition of the FGF inhibitor SU5402 (SU) to NOG+SB foregut cultures (For) caused a significant reduction of *SHH* and *PAX8* expression, but *NKX2.1, GLI1*, and *PTCH1* were not significantly different compared to the foregut controls, in which no growth factors were added after SB+NOG. (**C**) Addition of the HH inhibitor Sant-2 caused a significant reduction in *NKX2.1* compared to foregut control. Similarly when FGF2 (500 ng/ml) and Sant-2 were added simultaneously, the modest *NKX2.1* induction caused by FGF2 was significantly reduced whereas *PAX8* expression remained unchanged. (**D**) Foregut endoderm treated with SAG or SAG+SU for 8 days had a 6.5-fold and 21-fold increase of *NKX2.1* expression, respectively, compared to untreated foregut controls. *PAX8* expression was unchanged in the SAG treated cultures whereas SAG+SU treated cultures demonstrated a 41-fold decrease in *PAX8* expression. End = endoderm; For = foregut in all panels. \*p \< 0.05, error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.008](10.7554/eLife.05098.008)10.7554/eLife.05098.009Figure 2---figure supplement 1.Robust induction of NKX2.1 in foregut endoderm with HH stimulation and FGF inhibition.(**A**) Immunohistochemistry of NKX2.1 and PAX8 in endoderm controls, foregut controls or foregut cultures treated with SAG or SAG+SU. Treatment of foregut cultures with SAG or SAG+SU resulted in more NKX2.1+ cells compared to endoderm and foregut controls. Scale bars represent 200 µm and apply to all images. (**B**) Quantification showed that 20% ± 4% of cells in foregut controls were NKX2.1+, whereas 72% ± 3% cells were positive in SAG+SU treated cultures (\*p \< 0.05). All error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.009](10.7554/eLife.05098.009)

Based on these results, we further hypothesized that enhancing HH signaling would result in increased *NKX2.1* expression downstream of FGF, and that simultaneous inhibition of FGF signaling would reduce PAX8 expression; therefore, we inhibited endogenous FGF signaling with SU while activating HH with SAG ([Figure 2D](#fig2){ref-type="fig"}). This combination caused an additional increase in *NKX2.1* expression (21-fold vs 6.5-fold with SAG only, when compared to foregut) and a concomitant decrease in *PAX8* mRNA ([Figure 2D](#fig2){ref-type="fig"}). Importantly, immunofluorescence was correlated with QRT-PCR data showing an increased number of NKX2.1+ cells with the addition of SAG only. SAG+SU treated cultures showed a further increase in the number of NKX2.1 expressing cells, with ∼77% of all cells expressing NKX2.1 compared to ∼20% in foregut controls, and almost no PAX8 expressing cells ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). SAG and SAG+SU treated cells also co-expressed FOXA2 and SOX2 confirming their endodermal origin ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

HH-induced foregut spheroids give rise to human lung organoids (HLOs) {#s2-3}
---------------------------------------------------------------------

Based on the observations that stimulating HH and inhibiting FGF signaling strongly enhances NKX2.1 expression while reducing PAX8 expression ([Figure 2](#fig2){ref-type="fig"}), we tested multiple conditions of HH activation and FGF inhibition to induce NKX2.1^HI^/PAX8^LO^ foregut spheroids (NOG/SB/F/Ch) (Summarized in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Consistent with the important roles of FGF signaling in lung growth and branching morphogenesis ([@bib29]; [@bib50]; [@bib83]; [@bib1]; [@bib53]; [@bib63]), we found that conditions where FGF inhibition was used led to a reduction of epithelial tissue relative to mesenchymal tissue, which could be due to a loss of epithelium or an overgrowth of mesenchyme; this suggests that endogenous FGF signaling is necessary to maintain the epithelial tissue in 3D cultures ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Therefore, we also tested several conditions that stimulated HH signaling using SAG only, without FGF inhibition. We found that the most efficient method to enhance NKX2.1 expression was by adding SAG during the foregut spheroid phase ([Figure 3A](#fig3){ref-type="fig"}). Comparing foregut spheroids (NOG/SB/F/Ch) with those treated with SAG (NOG/SB/F/Ch/SAG), we observed a substantial decrease in *SOX2* expression compared to NOG/SB/F/Ch spheroids and a significant increase in *NKX2.1* mRNA. Additionally, nuclear NKX2.1 protein expression was found in ECAD+ epithelium which co-expressed endoderm epithelial markers FOXA2 and SOX2 ([Figure 3B,C](#fig3){ref-type="fig"}, [Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). Interestingly, during lung specification in mice, the gut tube initially expresses Sox2 throughout the endoderm, but Sox2 is down-regulated in the lung field during lung specification and Nkx2.1 induction ([@bib29]; [@bib69]; [@bib21]). Thus, concomitant down-regulation of *SOX2* and increased *NKX2.1* observed in SAG treated foregut spheroids is consistent with early transcriptional changes that occur during lung specification in mice.10.7554/eLife.05098.010Figure 3.HH-induced ventral foregut spheroids give rise to lung organoids.(**A**) hESCs were differentiated into foregut spheroids by treating cells with 4 days of ACTA and then an additional 4--6 days of NOG+SB+FGF4+Ch with the addition of the HH agonist SAG. Representative whole mount images of spheroids in a matrigel droplet are shown at low (left, scale bar 200 µm) and high magnification (right, scale bar 100 µm). (**B**) The addition of SAG to the NOG+SB+FGF4+Ch spheres caused a reduction in *SOX2* and *CDX2* transcripts (top panel) and a significant increase of *NKX2.1* transcript (bottom panel) compared to NOG+SB+FGF4+Ch spheres (without SAG). Other foregut lineages (*PAX8, PDX1, HHEX*) were not significantly different when SAG was added. (**C**) The majority of the cells in NOG+SB+FGF4+Ch+SAG spheres expressed FOXA2, SOX2 and NKX2.1 protein. Scale bars represent 50 µm. (**D**) Timeline showing NOG+SB+FGF4+Ch+SAG induced foregut spheroids grown and maintained in FGF10. Note that Day 1 is the day spheroids were plated in Matrigel. The scale bar represents 100 µm. (**E**) Organoids express lung markers in a manner consistent with mouse lung development. All expression is shown relative to undifferentiated pluripotent stem cells (hPSC), and adult human lung is shown as a reference. Lung progenitor markers *NMYC* and *ID2* were very low in adult lung, and were expressed at high levels in early organoid cultures, but were reduced over time (D = Days in culture), whereas *NKX2.1* expression remained relatively constant. In contrast, *SFTPC* is known to be expressed at low levels in distal lung progenitors, but increases and is highly expressed in AECII cells. Consistently, *SFTPC* is highly expressed in adult human lungs and increases over time in organoid cultures and the AECI marker *HOPX* is also highly expressed in adult human lung and increases over time in organoids. \*p \< 0.05. All error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.010](10.7554/eLife.05098.010)10.7554/eLife.05098.011Figure 3---figure supplement 1.Overview of conditions tested to generate human lung organoids.hPSCs are OCT4 and NANOG positive. After 4 days of 100 ng/ml Activin A, definitive endoderm (FOXA2 and SOX17 positive) was generated and then treated with two different conditions. In the top branch, NOG+SB+FGF4+Ch spheroids were generated, and different conditions were tested to promote lung organoid differentiation. In the bottom branch, NOG+SB+FGF4+Ch+SAG spheroids were generated, and different conditions were tested to promote lung organoid differentiation. Ultimately, we determined that spheroids generated with NOG+SB+FGF4+Ch+SAG and that were subsequently embedded in Matrigel and expanded in FGF10 gave rise to 'Human Lung Organoids' (HLOs).**DOI:** [http://dx.doi.org/10.7554/eLife.05098.011](10.7554/eLife.05098.011)10.7554/eLife.05098.012Figure 3---figure supplement 2.FGF-low culture conditions cause a loss of organoid epithelium over time.(**A**) NOG+SB+F+Ch foregut spheroids were generated and then cultured in SAG+SU for 10 days followed by 1% FBS ± FGF10. Timeline images show organoids cultured in 1% FBS. By day 20, 3D structures appeared 'fuzzy', which indicates an outgrowth of mesenchymal tissue. Scale bar represents 200 µm. (**B**) NOG+SB+F+Ch foregut spheroids treated with SAG+SU and maintained in 1% FBS showed an increase in Vimentin (VIM, green) immunofluorescence over time. Scale bar represents 50 µM. (**C**) NOG+SB+F+Ch foregut spheroids treated with SAG+SU and maintained in 1% FBS (upper panel) or 1% FBS+FGF10 (lower panel) had a significant increase of *VIM* expression starting at day 20 (D20) compared to hPSCs and showed very weak *E-CADHERIN* (*CDH1)* expression compared to D20 HLOS (optimized conditions, as described in [Figure 3](#fig3){ref-type="fig"}). Lastly, both conditions appeared to lose *NKX2.1* expression over time. (**D**) NOG+SB+F+Ch+SAG spheroids maintained in 1% FBS (basal media) also appear to lose epithelial structures over time. Scale bar represents 200 µm. (**E**) By day 20 (D20) the tissue had very few epithelial structures expressing ECAD (white, left panel) and there was robust VIM expression (green, right panel) at both time points. Scale bar represents 50 µm. HLO \*p \< 0.05. All error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.012](10.7554/eLife.05098.012)10.7554/eLife.05098.013Figure 3---figure supplement 3.Foregut spheroids express lung and foregut specific markers.(**A**) NOG/SB/FGF4/Ch/SAG spheroids coexpress NKX2.1 (green) and the endoderm marker FOXA2 (red). (**B**) The majority of the cells in the spheroid co-expresses SOX2 (green) and FOXA2 (red). Scale bars represent 50 µM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.013](10.7554/eLife.05098.013)10.7554/eLife.05098.014Figure 3---figure supplement 4.Ventral foregut spheroids do not express appreciable levels of PAX8 protein.Although NOG+SB+FGF4+Ch+SAG ventral foregut spheroids expressed *PAX8* mRNA ([Figure 3B](#fig3){ref-type="fig"}), we did not detect PAX8 protein in spheroids using immunofluorescence, whereas PAX8 protein in FGF2 8 day treated foregut monolayers (ACTA followed by NOG/SB) was readily detectable. Left panel: scale bar represents 50 µm. Right panel: scale bar represents 200 µm, inset scale bar represents 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.014](10.7554/eLife.05098.014)10.7554/eLife.05098.015Figure 3---figure supplement 5.Foregut spheroids consist of both epithelial and mesenchymal cells.NOG/SB/FGF4/Ch/SAG spheroids have a minor population of Vimentin (VIM, white) positive mesenchymal cells, while the majority of cells are epithelial and express ECAD (red). Scale bar represents 50 µM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.015](10.7554/eLife.05098.015)10.7554/eLife.05098.016Figure 3---figure supplement 6.Lung organoids contain both proximal and distal domains.NOG/SB/FGF4/Ch/SAG spheroids cultured for 15 days with FGF10 express the distal lung epithelium marker SOX9 (green) and proximal marker SOX2 (white) as separate domains in the epithelium labeled by ECAD (red). Z-stack images are shown every 40 µm sections through the HLO. Scale bar represents 200 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.016](10.7554/eLife.05098.016)

We also observed a slight, but non-significant increase in *PAX8* transcript level in NOG/SB/F/Ch/SAG treated foregut spheroids ([Figure 3B](#fig3){ref-type="fig"}). Importantly, PAX8 protein expression was undetectable in NOG/SB/F/Ch/SAG treated foregut spheroids and expression remained low/undetectable throughout time in culture. ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}). Similar to NOG/SB/F/Ch treated spheroids, the NOG/SB/F/Ch/SAG treated spheroids had a minor population of cells within the spheroids of mesodermal in origin, expressing Vimentin (VIM) ([Figure 3---figure supplement 5](#fig3s5){ref-type="fig"}).

NOG/SB/F/Ch/SAG treated foregut spheroids were embedded in Matrigel to provide a 3D growth environment. Spheroids maintained in basal media (see 'Materials and methods') supplemented with 1% FBS lost ECAD+ epithelial structures and were mainly comprised of mesenchyme within 20 days of 3D culture ([Figure 3---figure supplement 2D,E](#fig3s2){ref-type="fig"}). FGF10 is essential for branching morphogenesis and maintenance of lung progenitor cells during development as well as tissue homeostasis in the adult lung ([@bib4]; [@bib50]; [@bib83]; [@bib80]). We observed that the addition of FGF10 (500 ng/ml) allowed spheroids to expand and be passaged for over 100 days. FGF10 promoted the maintenance of ECAD+ epithelial structures with less mesenchymal contributions compared to both basal and FGF inhibitor conditions ([Figure 3D](#fig3){ref-type="fig"}). NOG/SB/F/Ch/SAG cultured for 15 days in FGF10 possessed abundant ECAD+ epithelium that expressed the proximal lung marker SOX2 and distal lung marker SOX9. SOX2+ domains and SOX9+ domains were distributed throughout the entire HLO as determined by whole mount immunofluorescence and confocal Z-sections. ([Figure 3---figure supplement 6](#fig3s6){ref-type="fig"}). FGF10 treated foregut spheroids maintained *NKX2.1* expression over time; however, consistent with mouse development, distal progenitor markers, *NMYC* and *ID2* mRNA expression decreased over time while distal Alveolar Type I and II cell markers, *HOPX* and *SFTPC* increased over time ([@bib60]; [@bib64]) ([Figure 3E](#fig3){ref-type="fig"}). These data suggest that HLOs pass through a stage resembling early fetal lung development in mice.

HLOs possess proximal airway-like structures {#s2-4}
--------------------------------------------

HLOs cultured longer than 2 months had striking epithelial structures resembling proximal airways, expressing proximal cell type-specific markers, including basal cells (P63), ciliated cells (FOXJ1, ACTTUB) and club cells (SCGB1A1) ([Figure 4](#fig4){ref-type="fig"}). Proximal-like airway tissues were often surrounded by a smooth muscle actin positive (SMA+) mesenchyme compartment. Although *P63* mRNA expression is maintained throughout culture ([Figure 4A](#fig4){ref-type="fig"}), it is only in prolonged cultures (\>2 months) where the P63+ cells are spatially arranged along the basal side of the epithelial tube-like structures, adjacent to SMA+ mesenchyme, similar to human bronchi and bronchioles ([Figure 4B](#fig4){ref-type="fig"}) ([@bib6]; [@bib56]; [@bib23]; [@bib66]). By 65 days in vitro (D65) proximal-like epithelial structures form a cyst-like structure that expresses P63, as determined by whole mount immunofluorescence staining and confocal z-stacks. Moreover, SMA expression is strongest at the periphery of the HLO ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). P63+ proximal airway-like cells also co-express SOX2 and NKX2.1 as determined on serial sections ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Located on the luminal surface of HLO proximal airway-like structures are cells expressing the multi-ciliated cell transcription factor FOXJ1 ([Figure 4B](#fig4){ref-type="fig"}). Very few cells expressed the club cell marker SCGB1A1, and this protein was observed in a pixilated expression pattern ([Figure 4D](#fig4){ref-type="fig"}). Multi-ciliated and club cell specific mRNAs, *FOXJ1* and *SCGB1A1* respectively, were significantly increased in prolonged HLO culture ([Figure 4A](#fig4){ref-type="fig"}). Although the goblet cell marker *MUC5AC* mRNA expression was detected, protein expression was not detected by immunofluorescence ([Figure 4A](#fig4){ref-type="fig"} and data not shown).10.7554/eLife.05098.017Figure 4.Lung organoids form proximal airway-like structures.(**A**) Genes expressed in the proximal airway were examined in organoids across time. The proximal airway cell marker *SOX2* decreased over time in HLOs cultures compared to D10 HLOs. Compared to undifferentiated hPSCs, organoids expressed high levels of the basal cell marker *P63* at all time points, while expression of the club cell marker *SCGB1A1* and ciliated cell marker *FOXJ1* increased significantly in prolonged cultures (compared to D10 HLOs). There was an increasing but non-significant trend in goblet cell *MUC5AC* expression over time in culture. (**B**) D65 HLOs had structures resembling the proximal airway, in which the epithelium (β-catenin, red) possesses P63+ basal cells (green), and is surrounded by SMA+ (white, upper and lower left panel) mesenchymal tissue. Adjacent to the P63 positive basal cell layer (green, lower, right panel) were FOXJ1 positive cells (white). Scale bars represent 50 µM (top) and 10 µM (bottom). (**C**) Proximal airway-like epithelium (β-catenin, green) co-stained for ACTTUB on the apical side of the cell (red). Scale bars represent 50 µM (top) and 10 µM (bottom). (**D**). Proximal airway-like epithelium (E-cadherin, red) also co-stained with Club cell marker CC10 (white, right panel). Scale bars represent 50 µM (top) and 10 µM (bottom). (**E**) Acellular human lung matrix was seeded with spheroids and cultured for 40 days (D40). Matrices had abundant proximal airway-like structures that had multi-ciliated cells on the apical surfaced labeled by ACTTUB (red, top panel) in low (scale bar 50 µM) and high magnification (scale bar 10 µM). Serial sections showed that cells were also FOXJ1 positive (white, lower panel) with the epithelium outlined in ECAD (green) in low (scale bar 50 µM) and high magnification (scale bar 10 µM). (**B**--**D**) 'L' in high magnification images indicates the lumen. \*p \< 0.05. All error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.017](10.7554/eLife.05098.017)10.7554/eLife.05098.018Figure 4---figure supplement 1.Lung organoids have P63+ epithelium throughout the organoid.(**A**) Confocal Z-slices taken at every 40 µm show P63+ (green) and ECAD+ (white) structures through the D65 HLO. (**B**) Z-slices taken at every 40 µm show SMA (white) surrounding the periphery the HLO with P63 (green) staining within the HLO. Scale bars represent 200 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.018](10.7554/eLife.05098.018)10.7554/eLife.05098.019Figure 4---figure supplement 2.P63+ cells have an NKX2.1+ lung identity.(**A**) Serial sections were stained with NKX2.1 and P63 respectively. The adjacent sections expressed ECAD (white) and NKX2.1 (green) in the first section and P63 (green) in the second section. (**B**) P63+ cells (green) co-expressed the proximal lung marker SOX2 (red) in the epithelium labeled by ECAD (white). Scale bars represent 50 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.019](10.7554/eLife.05098.019)

Although the multi-ciliated cell transcription factor FOXJ1 was abundant in proximal airway-like structures, we observed that ACTTUB was localized to the apical side of these cells, but did not appear to be localized to cilia on the apical cell surface ([Figure 4C](#fig4){ref-type="fig"}), suggesting that this may represent a cell that has not fully differentiated. Others have demonstrated that robust differentiation of multi-ciliated cells from hPSCs require modified culture conditions to promote differentiation of functional cell types ([@bib24]). Thus, it is possible that the HLO environment, such as Matrigel or media rich in FGF10, does not promote terminal differentiation of all cell types. In order to alter the HLO environment, we seeded NOG/SB/F/Ch/SAG foregut spheroids onto an acellular human lung matrix ([@bib7]). Spheroids seeded on slices of acellular lung matrix predominantly gave rise to proximal airway-like structures in which stereotypical tufts of ACTTUB positive ciliated structures on the apical surface of cells were observed facing into a lumen. In serial sections, these airways had abundant FOXJ1+ cells ([Figure 4E](#fig4){ref-type="fig"}). Thus, HLOs have the capacity to generate more mature ciliated cells given the correct stimulus or environment.

As noted, proximal airways are often closely associated with the SMA+ mesenchyme ([Figure 4B](#fig4){ref-type="fig"}) whereas in the adult murine lung, proximal airways are also associated with Pdgfrα+ and Vim+ mesenchymal cells ([@bib8]; [@bib30]; [@bib13]). Thus, we investigated the mesenchymal population within the HLOs in more detail. Immunofluorescence revealed that D65 HLOs have both PDGFRα+/VIM+ double positive and PDGFRα−/VIM+ cell populations, which is indicative of myofibroblasts and fibroblasts respectively ([Figure 5A](#fig5){ref-type="fig"}). Adult murine myofibroblasts also co-express Sma and Pdgfrα whereas differentiated smooth muscle is Sma+/Pdgfra− ([@bib41]; [@bib45]; [@bib8]; [@bib30]; [@bib13]), and we observe PDGFRα+/SMA+ and PDGFRα−/SMA+ populations of cells indicating that HLOs possess myofibroblasts and smooth muscle cells ([Figure 5B](#fig5){ref-type="fig"}). The HLOs did not stain positive for Safranin O indicating there is no cartilage tissue, whereas iPSC derived teratomas had abundant cartilage ([Figure 5C](#fig5){ref-type="fig"}). Taken together, the HLO mesenchymal population is diverse with myofibroblasts, fibroblasts, and smooth muscle cells.10.7554/eLife.05098.020Figure 5.Lung organoids possess multiple types of mesenchymal cells.(**A**) D65 HLOs have PDGFRα+ (green) VIM+ (white) double-positive myofibroblasts and PDGFRα−/VIM+ fibroblasts. Scale bar represents 50 µm. (**B**) D65 HLOs also possesses PDGFRα+ (green) SMA+ (white) double-positive myofibroblasts and PDGFRα−/SMA+ smooth muscle and myofibrblasts. Scale bar represents 50 µm. (**C**) D65 HLOs do not contain any cartilage whereas positive control iPSC derived teratoma had clear Safranin O staining specific to cartilage. Fast green marks the cytoplasm and hematoxylin the nuclei of both tissues. Scale bar represents 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.020](10.7554/eLife.05098.020)

HLOs possess immature alveolar airway-like structures {#s2-5}
-----------------------------------------------------

The distal lung epithelium in mouse and human make up the gas-exchanging alveoli, consisting of type I and type II alveolar epithelial cells (AECI, AECII). During development, the distal lung epithelium expresses progenitor markers including SOX9, ID2, and NMYC ([@bib60]; [@bib64]; [@bib12]; [@bib67]). All distal markers are present in the HLOs; however, *ID2* and *NMYC* are expressed at high levels in early cultures, but are down regulated in prolonged culture ([Figure 3F](#fig3){ref-type="fig"}) while *SOX9* expression remains consistent across time in culture ([Figure 6A](#fig6){ref-type="fig"}).10.7554/eLife.05098.021Figure 6.Lung organoids possess abundant distal bipotent progenitor cells.(**A**) The expression of the distal progenitor marker *SOX9* remained unchanged over time and expression of the AECI marker *PDPN* was low in HLO cultures. (**B**) The majority of SFTPC+ cells (green, left panel) co-expressed SOX9 (red). Similarly, many cells expressing the AECI early marker HOPX+ (green, right panel) co-expressed SOX9 (red). Few, scattered cells expressed the late AECII marker SFTPB (white, second panel) or the AECI marker, PDPN (third panel, white). Few PDPN+ cells also showed elongated, squamous morphology seen in the adult lung. (**C**) Human lung AECII cells labeled with SFTPC (green, left panel) did not co-express SOX9. SFTPB+ cells (white, second panel) in the adult human lung have similar morphology to SFTPB+ cells in HLOs. Human lung AECI cells expressed PDPN (white, third panel), and show characteristic AECI cell shape. Human AECI cells express HOPX (green, right panel), but did not co-express SOX9. (**B**--**C**) Scale bar in lower magnification images in B (upper panel) represent 50 µM and the scale bars in higher magnification images in **B**, **C** (lower panel) represent 10 µM. (**D**) D50 HLOs contain lamellar bodies which are organelles specific to AECII cells. Scale bars represent 500 nm.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.021](10.7554/eLife.05098.021)10.7554/eLife.05098.022Figure 6---figure supplement 1.SFTPC+ cells express lung specific markers.D65 HLOs express lung epithelial markers NKX2.1 (green) and SOX9 (red) and the adjacent section expresses SFTPC (green) and SOX9 (red). Scale bar represents 50 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.022](10.7554/eLife.05098.022)

Recently, there have been major advances in mice toward defining a bipotent alveolar progenitor population during the late fetal/early neonatal period ([@bib20]; [@bib78]), and this work has highlighted the fact that many markers previously considered terminal differentiation markers are co-expressed in the bipotent progenitors. Specifically, the AECII marker SftpC and AECI marker Hopx can be co-expressed in a bipotent progenitor before becoming committed to one lineage or the other. Moreover, we have shown that Sox9 marks an early progenitor population in the developing mouse lung and Sox9 also marks the bipotent progenitor in late fetal life ([@bib67]; [@bib78]). In HLOs grown in prolonged culture (\>2 months), we observed that AECII (SFTPC, SFTPB) and AECI (PDPN, HOPX) cell-type markers were present ([Figure 6A--B](#fig6){ref-type="fig"}). However, we also observed that *SFTPC* levels were very low ([Figure 3F](#fig3){ref-type="fig"}), and that SFTPB+ cells were rare ([Figure 6B](#fig6){ref-type="fig"}). This suggested that the distal airway cells present in HLOs might be a progenitor-like population. To test this possibility, we co-stained SFTPC (AECII) or HOPX (AECI) with SOX9 and found abundant SFTPC/SOX9 and HOPX/SOX9 double positive cells ([Figure 6B](#fig6){ref-type="fig"}). Co-staining in serial sections suggests that SFTPC/SOX9 double positive cells are also NKX2.1+ ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). In contrast these co-expressing cells were not found in the adult human lung ([Figure 6C](#fig6){ref-type="fig"}). Although rare, the few SFTPB+ observed in HLOs resemble AECII cells seen in the adult human lung, and PDPN+ cells resembled the elongated AECI cells in the human lung ([Figure 6B--C](#fig6){ref-type="fig"}). In order to improve confidence that cells expressing AECII markers are AECII cells, we used transmission electron microscopy (TEM) to determine if HLOs possessed cells containing lamellar bodies, which are necessary for surfactant protein trafficking and secretion ([@bib68]; [@bib73]; [@bib84]). Using TEM, we observed lamellar bodies both in cells within HLOs, and in open spaces between cells, indicating that lamellar bodies are being secreted ([Figure 6D](#fig6){ref-type="fig"}). Taken together, our data suggests that HLOs predominantly possess undifferentiated alveolar progenitor cells with rare differentiated AECI and AECII cells interspersed throughout the distal-like tissue.

Quantitative assessment of HLO composition {#s2-6}
------------------------------------------

We have shown that HLOs have both proximal-like and distal-like epithelium in addition to surrounding mesenchymal tissue. In order to better gauge the composition of HLOs, we performed a detailed quantitative analysis of cell types and structures. We sectioned 48 individual HLOs, and examined them for P63+ proximal airway-like structures (as shown in [Figure 4B--D](#fig4){ref-type="fig"}), and distal-airway like structures (as shown in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We found that 39/48 (81%) of the HLOs have proximal airway epithelial structures while 48/48 (100%) of HLOs have distal airway-like structures ([Figure 7A](#fig7){ref-type="fig"}). We then calculated the average cross-sectional area comprised of P63+ proximal airway-like and P63−/SFTPC+ distal airway-like tissue and found that proximal structures comprised 14.5% (±0.6%) of the entire area of the HLO, whereas 85.5% (±0.6%) were distal in nature (including epithelium and mesenchyme) ([Figure 7B](#fig7){ref-type="fig"}). To determine the percentage of certain cell types within an HLO, we sectioned and stained 15 individual HLOs (n = 15) and counted cells positive for specific markers, and the total number of Dapi+ nuclei within a section ([Figure 7C--G](#fig7){ref-type="fig"}). On average, 57% of all cells in the HLOs were NKX2.1+ ([Figure 7C](#fig7){ref-type="fig"}), 39% of all cells were P63+, 3% were FOXJ1+, 5% were SFTPC+, and 4% of all cells were HOPX+ ([Figure 7D--G](#fig7){ref-type="fig"}).10.7554/eLife.05098.023Figure 7.Quantitative assessment of the composition of lung organoids.(**A**) HLOs were assessed for proximal airway-like structures (P63+) and distal airway-like structures (P63−/SFTPC+). 81% of HLOs have proximal airway-like epithelium while 100% have distal airway-like epithelium (n = 48 individual HLOs). (**B**) The average cross-sectional area within an HLO that is comprised of P63+ proximal airway-like and P63−/SFTPC+ distal airway-like epithelium was calculated. Proximal structures comprised 14.5% (±0.6%) of the entire area of the HLO (P63+), whereas 85.5% (±0.6%) of HLO was distal-like epithelium and mesenchyme (P63−). (**C**--**G**) The percent of specific cell markers present in an organoid was determined by dividing by the total number of DAPI+ nuclei within the same section (n = 15 individual HLOs). Each point represents the data from an individual HLO while the open bar represents the average percent of cells. (**C**) On average, 57% of all cells in the HLOs were NKX2.1+, (**D**) 39% of all cells were P63+, (**E**) 3% were FOXJ1+, (**F**) 5% were SFTPC+, (**G**) 4% of all cells were HOPX+. (**B**--**G**) Error bars represent SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.023](10.7554/eLife.05098.023)

HLOs are globally similar to human fetal lung {#s2-7}
---------------------------------------------

Accumulating evidence suggests that HLOs are immature. For example, distal progenitor markers are initially robustly expressed whereas SFTPC expression is very low across time in HLOs ([Figure 3E](#fig3){ref-type="fig"}), FOXJ1+ cells do not appear to form mature multi-ciliated structures until placed onto a decelluarized lung matrix ([Figure 4B,E](#fig4){ref-type="fig"}) and rare SCGB1A1+ cells do not resemble mature club cells ([Figure 4D](#fig4){ref-type="fig"}). Moreover, the majority of the distal-like epithelium expresses bipotent progenitor markers ([Figure 5](#fig5){ref-type="fig"}). In order to directly address the maturity of HLOs, we conducted RNA-sequencing (RNAseq) on HLOs (n = 6; 3 D65 HLOs, 3 D110 HLOs), on undifferentiated hESCs and on definitive endoderm. We also took advantage of publicly available RNAseq datasets for human fetal lung representing a range of gestational stages, and for adult human lung ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). In order to determine global similarity among these tissues relative to HLOs, we conducted principal component (PC) analysis ([Figure 8A,B](#fig8){ref-type="fig"}) ([@bib65]), hierarchical clustering ([Figure 8C](#fig8){ref-type="fig"}) ([@bib22]) and Spearman\'s rank-order correlation ([@bib33]) matrix analysis ([Figure 8D](#fig8){ref-type="fig"}) of the complete tabulated FPKM matrix generated from RNA sequences datasets and representing the total gene expression complement in each sample. Consistent across all three types of informatics analysis, transcriptional activity in the HLOs shares the greatest degree of similarity to human fetal lung. These data strongly suggest that global transcription of HLOs is highly similar to human fetal lung, and support the idea that HLOs are in a less differentiated, fetal state when grown in the conditions described here.10.7554/eLife.05098.024Figure 8.RNA sequencing analysis associates HLOs with fetal lung tissue.6 HLOs (n = 3 D65 HLOs and n = 3 D110 HLOs) were compared to the undifferentiated H9 stem cells (SC) and definitive endoderm (Def End) and publicly available datasets of adult and fetal human lungs (see [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). (**A**--**B**) Plot of the first three principle components generated in the principle component (PC) analysis as pairwise 2-dimensional plots (**A**) or as an aggregate 3-dimensional projection (**B**), (**C**) hierarchical clustering, and (**D**) Spearman\'s correlation all demonstrate that HLOs are most closely related to the fetal lung.**DOI:** [http://dx.doi.org/10.7554/eLife.05098.024](10.7554/eLife.05098.024)

Discussion {#s3}
==========

To date, a number of groups have defined methods to generate lung specific cell types utilizing 2D culture systems ([@bib27]; [@bib44]; [@bib55]; [@bib87]; [@bib26]; [@bib32]). Although lung lineage cells have been generated with varying efficiency (∼30--80% NKX2.1+ cells \[[@bib87]; [@bib32]; [@bib24]\]) and can generate both both proximal (∼5--36% of cells \[[@bib87]; [@bib32]; [@bib24]\]) and distal cell types (up to ∼50% of cells \[[@bib32]\]), proper spatial organization of the cell types and specific tissue morphology have not been reported in 2D systems. Here, we show that HLOs possess both mesenchymal and lung epithelial (∼60% NKX2.1+) cells with proximal airway-like structures that possess P63+ (∼40%) and FOXJ1+ cells (∼3%) along with distal airway-like structures that possess SFTPC+ (∼5%) and HOPX+ (∼4%) cells.

It is currently unclear if 2D culture systems described have the capability to give rise to mesodermal lineages. Thus, HLOs allow one to address questions regarding spatial tissue organization and epithelial-mesenchymal interactions. Since HLOs form organized structures that resemble bronchi and bronchioles with adjacent mesenchyme, these complex, organized tissues may allow exploration, for example, of airway remodeling after injury. Moreover, the spatial arrangement of specific cell types will be critical to study proximal airway dynamics during homeostasis and injury. For example, the location of P63+ cells adjacent to FOXJ1+ cells in the HLOs will be necessary to study basal cell differentiation into different proximal airway cell types during homeostasis or after injury. In addition to tissue morphology and structure during prolonged culture, the HLOs consist of both epithelium and mesenchyme in early cultures that are maintained over time. Since lung development requires extensive cross talk between the epithelium and mesenchyme in order to regulate developmental processes, proliferation and differentiation, HLOs may be an ideal in vitro system to study these complex tissue--tissue interactions.

Recently, there has been a push to define progenitor populations during lung development and adult homeostasis in order to better understand differentiation and the transition between branching and alveolarization. Two groups have defined a bipotent progenitor population in the embryonic/neonatal lung that gives rise to both AECI and AECII cells ([@bib20]; [@bib78]). These bipotent cells express the distal progenitor marker Sox9 along with differentiation markers of AECI and AECII cells, including SftpC, HopX, and Pdpn. We demonstrate that HLOs expressed both AECI and II markers; however, the majority of these cells also expressed SOX9 suggesting that the majority of the distal epithelium is comprised of bipotent progenitors. Thus, HLOs will allow us to gain insight into this bipotent population, explore how bipotent progenitors are regulated, and define the mechanisms of how fate-decisions are made as terminal differentiation occurs.

The evidence supporting that HLOs are fetal in nature could reflect the fact that a block to full maturation exists in vitro, as is the case with other endoderm lineage organoids (intestinal and gastric), which appear to be immature. That is, while they possess committed lineage-specific cell types, the cells may not exhibit fully matured adult-like function ([@bib48]; [@bib82]). This is also the case for pancreatic β-like cells and hepatocyte-like cells generated in vitro ([@bib70]; [@bib31]). Alternatively, the progenitor state may reflect the high levels of FGF10 in the culture media, since FGF10 is known to maintain progenitor cells in the lung ([@bib62]; [@bib59]). Given that HLOs are similar to human fetal lung, this tissue is an ideal model to study lung maturation of both the proximal and distal epithelium along with epithelial-mesenchymal interactions in a developmental context.

While the multi-lineage, multi-cellular composition of HLOs is a major advantage, one of the caveats to this system is that HLOs do not appear to undergo *bona fide* branching morphogenesis or possess transitional zones found in the adult lung, such as the bronchioalveolar ductal junction (BADJ). The HLOs possess proximal SOX2+ domain and distal SOX9+ domains observed during branching morphogenesis, but this regionalization occurs without setting up the stereotyped branching pattern. This may be due to the fact that the organoids are surrounded by media supplemented with FGF10 compared to the in vivo situation where FGF10 is expressed in a dynamic, spatially restricted manner in the distal mesenchyme ([@bib5]; [@bib59]; [@bib1]). However, it has recently been demonstrated that localized expression FGF10 is not required for branching ([@bib80]), so this may not explain the lack of branching. Alternatively, similar to other endoderm-derived organoid models, HLOs lack several components of the native organ, including immune cells, vasculature, and innervation. Thus, it is possible that cellular inputs important for branching morphogenesis are missing from HLOs. Indeed, recent reports have shown that innervation is required for proper branching ([@bib9]), and while vasculature may not be important for lung branching ([@bib28]), others have shown the vascular endothelium is required to induce a branching-like program of isolated airway epithelium in 3D cultures ([@bib25]). Lastly, the microenvironment is essential for branching morphogenesis to occur including dynamic changes in the extracellular matrix around branching lung bud tips where the ECM is constantly changing and interacting with the cytoskeleton of the branching epithelium in order to facilitate cell movement and branching bifurcations ([@bib52]; [@bib35]; [@bib81]). It is possible that in the future, co-culture with additional cellular inputs may prove to enhance HLO branching.

Taken together, we describe here a novel system to generate human lung organoids from human pluripotent stem cells. HLOs possess both mesenchymal and epithelial lineages, as well as organized proximal airway structures with multiple cell types and surrounded by mesenchyme. HLOs also possess distal epithelial cells that are reminiscent of a bipotent alveolar progenitor cell recently described in mice which is likely a reflection of the similarities of HLOs to the human fetal lung. We believe that HLOs will be an excellent new human system to model lung differentiation, homeostasis and disease in vitro.

Materials and methods {#s4}
=====================

Maintenance of hESCs {#s4-1}
--------------------

Human ES cell lines H1 (NIH registry \#0043) and H9 (NIH registry \#0062) were obtained from WiCell Research Institute. Human ES line UM77-2 (NIH registry \#0278) was obtained from the University of Michigan. iPSC lines 3-5 and 20-1 were generated at Cincinnati Children\'s Hospital and have been previously described ([@bib72]). Stem cells were maintained on Matrigel (BD Biosciences, San Jose, CA) in mTeSR1 medium (STEMCELL Technologies, Vancouver, Canada). HESCs were passaged as previously described ([@bib72]).

Differentiation of PSCs into definitive endoderm {#s4-2}
------------------------------------------------

Differentiation into definitive endoderm was carried out as previously described ([@bib16]; [@bib72]). Briefly, a 4-day Activin A (R&D systems, Minneapolis, MN) differentiation protocol was used. Cells were treated with Activin A (100 ng ml^−1^) for 3 consecutive days in RPMI 1640 media (Life Technologies, Grand Island, NY) with increasing concentrations of 0%, 0.2% and 2% HyClone defined fetal bovine serum (dFBS, Thermo Scientific, West Palm Beach, FL).

Differentiation of definitive endoderm into anterior foregut {#s4-3}
------------------------------------------------------------

After differentiation into definitive endoderm, foregut endoderm was differentiated, essentially as described ([@bib27]). Briefly, cells were incubated in foregut media: Advanced DMEM/F12 plus N-2 and B27 supplement, 10 mM Hepes, 1× L-Glutamine (200 mM), 1× Penicillin-streptomycin (5000 U/ml, all from Life Technologies) with 200 ng/ml Noggin (NOG, R&D Systems) and 10 µM SB431542 (SB, Stemgent, Cambridge, MA) for 4 days. For long term maintenance, cultures were maintain in 'basal' foregut media without NOG and SB, or in the presence of growth factors including 50, 500 ng/ml FGF2 (R&D systems), 10 µM Sant-2 (Stemgent), 10 µM SU5402 (SU, Stemgent), 100 ng/ml SHH (R&D systems), and SAG (Enzo Life Sciences, Farmingdale, NY) for 8 days.

Directed differentiation into anterior foregut spheroids and lung organoids {#s4-4}
---------------------------------------------------------------------------

After differentiation into definitive endoderm, cells were incubated in foregut media with NOG, SB, 500 ng/ml FGF4 (R&D Systems), and 2 µM CHIR99021 (Chiron, Stemgent) for 4--6 days. After 4 days with treatment of growth factors, three-dimensional floating spheroids were present in the culture. Three-dimensional spheroids were transferred into Matrigel to support 3D growth as previously described ([@bib47]). Briefly, spheroids were embedded in a droplet of Matrigel (BD Bioscience \#356237) in one well of a 24 well plate, and incubated at room temperature for 10 min. After the Matrigel solidified, foregut media with 1% Fetal bovine serum (FBS, CAT\#: 16000--044, Life Technologies) or other growth factors and small molecules were overlaid and replaced every 4 days. Organoids were transferred into new Matrigel droplets every 10--15 days.

Immunohistochemistry {#s4-5}
--------------------

Immunostaining was carried out as previously described ([@bib71]; [@bib67]). Antibody information and dilutions can be found in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}. All images were taken on a Nikon A1 confocal microscope or an Olympus IX71 epifluorescent microscope.

RNA extraction and qRT-PCR {#s4-6}
--------------------------

RNA was extracted from monolayers, spheroids, and organoids using a MagMAX-96 Total RNA Isolation Kit (Life Technologies) and MAG Max Express (Applied Biosystems, Grand Island, NY). RNA quantity and quality were determined spectrophotometrically, using a Nano Drop 2000 (Thermoscientific). Reverse transcription was conducted using the SuperScript VILO kit (Invitrogen, Grand Island, NY), according to manufacturer\'s protocol. Finally, qRT-PCR was carried out using Quantitect Sybr Green MasterMix (Qiagen) on a Step One Plus Real-Time PCR system (Life Technologies). For a list of primer sequences see [Supplementary file 3](#SD3-data){ref-type="supplementary-material"}.

Seeding lung spheroids on decellularized human lung matrices {#s4-7}
------------------------------------------------------------

Human lungs deemed to be unsuitable for lung transplantation were obtained from beating-heart (or warm autopsy) donors through Gift of Life Michigan and lungs were decellularized as previously described ([@bib7]). Slices were prepared using a sterile tissue punch (Fisher) and sterilized with 0.18% peracetic acid and 4.8% EtOH. Matrix slices were placed in a 96 well plate and approximately 50 NOG+SB+F+Ch+SAG spheres were pipetted directly onto the matrices. Samples were centrifuged for 2 min at 2000 rpm and then incubated at 37°C for 30 min without media. Foregut media supplemented with 1% FBS and 500 ng/ml FGF10 was then added to the matrices. Media was changed daily.

Transmission electron microscopy {#s4-8}
--------------------------------

D50 HLOs were processed as previously described ([@bib61]; [@bib67]). 70 nm sections were sections were imaged using a Philips CM-100 electron microscope.

Area and cell quantification {#s4-9}
----------------------------

HLOs with P63+ cells were counted as having proximal airway-like epithelium and HLOs with SFTPC+ cells were counted as having distal airway-like epithelium. The area of proximal epithelium was determined by P63+ECAD+ staining. Area was measured using ImageJ software. Cell quantification of NKX2.1, P63, and DAPI was counted by Metamorph cell counting software. FOXJ1, SFTPC, and HOPX were counted in ImageJ using the cell counter plugin.

Statistical analysis and experimental replicates {#s4-10}
------------------------------------------------

All immunofluorescence and qRT-PCR experiments were carried out at least two times with three (n = 3) independent biological samples per experiment. The only exceptions to this were experiments that included human adult lung samples in the analysis. For these experiments, n = 1 biological human lung sample was used in statistical replicates (triplicates) whereas all other samples used biological replicates (n = 3). For quantification in [Figure 7](#fig7){ref-type="fig"}, a total of 48 different HLOs (n = 48) were counted for HLO composition. For the proximal epithelial area, 29 different HLOs were counted (n = 29). For cell quantification, 15 different HLOs were counted (n = 15). Statistical differences between groups were assessed with Prism software, using multiple t tests. All error bars represent SEM. Results were considered statistically significant at p \< 0.05.

RNA sequencing and analysis {#s4-11}
---------------------------

Sequencing of HLOs (n = 3 D65, n = 3 D110) was performed by the University of Michigan DNA Sequencing Core, using the Illumina Hi-Seq platform. Sequencing of H9 Stem Cells (SC) and Definitive Endoderm (DE) was performed by the University of California, San Francisco DNA Sequencing Core using the Illumina Hi-Seq platform. All sequences were deposited in the EMBL-EBI ArrayExpress database using Annotare 2.0 and are catalogued under the accession number E-MTAB-3339 for the HLOs and E-MTAB-3158 for SC and DE. The University of Michigan Bioinformatics Core obtained the reads files and concatenated those into a single '.fastq' file for each sample. The Bioinformatics Core also downloaded reads files from EBI-AE database (Adult lung Samples) and NCBI-GEO (SRA) database (Fetal lung samples) ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). The quality of the raw reads data for each sample was evaluated using FastQC (version 0.10.1) to identify features of the data that may indicate quality problems (e.g., low quality scores, over-represented sequences, inappropriate GC content, etc). Initial QC report indicated over-representation of Illumina adapter sequences in samples from EBI-AE data set and NCBI-GEO data set. Adapter sequences were trimmed from the reads using Cutadapt (version 0.9.5) ([@bib15]). Briefly, reads were aligned to the reference transcriptome (UCSC hg19) using TopHat (version 2.0.9) and Bowtie (version 2.1.0.0) ([@bib40]). Cufflinks/CuffNorm (version 2.2.1) was used for expression quantitation and differential expression analysis ([@bib77]), using UCSC hg19.fa as the reference genome sequence and UCSC hg19.gtf as the reference transcriptome annotation. For this analysis, we used parameter settings: '--multi-read-correct' to adjust expression calculations for reads that map in more than one locus, as well as '--compatible-hits-norm' and '--upper-quartile --norm' for normalization of expression values. Normalized FPKM tables were generated using the CuffNorm function found in Cufflinks. Transcriptional quantitation analysis in Cufflinks was conducted using the 64-bit Debian Linux stable version 7.8 ('Wheezy') platform. The complete FPKM matrix, containing frequency counts for all 24,010 genes contained in the reference genome for all 23 RNAseq samples, was evaluated using unscaled principle component analysis (PCA) to visualize and quantify multi-dimensional variation between samples ([@bib65]). Of the 24,010 genes annotated in the reference genome, 2815 (11.7%) were not detected in the RNAseq analysis of any of the 23 samples. Principle components were calculated using the function 'prcomp' found in the R (version 3.1.2) statistical programming language (<http://www.R-project.org/>) and plotted using the R package 'ggplot2' ([@bib86]). Hierarchical cluster analysis based on the Canberra distance ([@bib22]) between FPKM vectors was used to classify discrete RNAseq samples according to the degree of total transcriptional dissimilarity indicated by the normalized FPKM values. Bootstrap analysis was used to assess the uncertainty in the assigned hierarchical clustering relationships. 10,000 bootstraping iterations were generated by repeatedly randomly sampling the FPKM dataset. The bootstrap probability (BP) of a cluster is defined as the frequency of a given relationship among the bootstrap replicates. Multiscale bootstrap resampling was used to calculate an approximately unbiased (AU) p-value for a given relationship, with AU \> 95 indicating a high degree of statistical significance. Analyses were conducted using R package 'pvclust' ([@bib75]). Spearman correlation was applied as an additional assessment of the cumulative degree of correlation among RNAseq datasets. In addition, we computed Spearman rank correlation coefficients (ρ) in a pairwise manner among all 23 RNAseq samples using the complete normalized FPKM data. The Spearman coefficients were plotted as a heatmap using the function 'heatmap.2' in the R package 'gplots' ([http://CRAN.R-project.org/package=gplots](http://cran.r-project.org/package=gplots)). Complete data analysis scripts are available at <https://github.com/hilldr/HLO_eLife2015>.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "In vitro generation of human pluripotent stem cell derived lung organoids" for consideration at *eLife*. Your article has been favorably evaluated by Janet Rossant (Senior editor and Reviewing editor) and 2 reviewers.

The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

In this study, the authors describe a systematically delineated 3D protocol to generate human lung organoids from human pluripotent stem cells. HLOs possess organized proximal airway structures with apparently multiple differentiated epithelial cell types, as well as smooth muscle cells. There was enthusiasm for the overall concept and the potential of the system to be used to model lung differentiation, homeostasis and disease in vitro. This work should be of interest to the readership of *eLife*. However, there were concerns raised about the lack of in depth characterization of the different cell types generated and the lack of careful quantification of the extent of ordered differentiation in the system. For the paper to be reconsidered, we would ask you to address the various specific comments below, but to focus on careful characterization of the different lung cell types generated by extensive use of confocal imaging of co-staining with appropriate antibodies, such as FOXJ1, beta-tubulin, CC10, SCGB1A1, SCGB3A2, P63, Podoplanin, HOPX1, and more markers of SM compartment. It would also be important to provide more evidence that the organoids really regenerate at least partially the ordered branching seen in the lung- such that you could define a bronchioalveolar duct junction (BADJ) with the proper smooth muscle configuration. Further definition of the cell types arising from the mesenchyme would also be useful. Are there any cartilage cells or other types of cells such as lipofibroblasts, myofibroblasts, etc.

In addition, some quantification of the proportions of different cell types produced and comparison with other published lung differentiation protocols is required. We recognize that functional assessment of the cell types produced is difficult but use of EM identify lamellar bodies in type 2 cells would help.

Specific comments:

Reviewer \#1:

[Figure 1](#fig1){ref-type="fig"}: Foregut endoderm should be characterized by double positive for FOXA2+SOX2+. SOX2 single expression is not enough for anterior endoderm identification.

[Figure 2](#fig2){ref-type="fig"}: especially [Figure 2--figure supplement 1](#fig2s1){ref-type="fig"}. In order to ensure NKX2.1+ are endoderm derived lung progenitors, co-staining with a battery of markers including FOXA2, SOX9, ID2, FOXP2 etc. are needed for comprehensive characterization.

[Figure 3](#fig3){ref-type="fig"}: In the text, the authors claimed that most spheres co-expressed FOXA2, SOX2, and NKX2.1 protein. However, only single marker staining was shown. Double and triple staining is highly recommended.

[Figure 3E](#fig3){ref-type="fig"}: the authors claimed that their lung organoids contains bipotent alveolar progenitor markers including NMYC, ID2, NKX2.1, SPC, and HOPX based on their q-PCR analysis. Those differentiated markers need to validated with double or triple co-staining.

In supplemental figures for [Figure 3](#fig3){ref-type="fig"}, the authors indicated that the majority of cells lose epithelial identity and become vimentin positive mesenchymal cells over time. It is also still possible that mesenchyme overgrew epithelium.

[Figure 4](#fig4){ref-type="fig"}: Most differentiation marker staining is of poor quality and hard to interpret. For example, acetylated tubulin staining for ciliated cell is within the cell, rather than extend outside of the cell like cilia ([Figure 4C](#fig4){ref-type="fig"}). CCSP is dot-like ([Figure 4C](#fig4){ref-type="fig"}). P63 expression is a general epithelial stem cell markers, therefore co-staining of P63 with NKX2.1, FOXA2 and SOX2 are needed to ensure they are airway epithelial stem cells ([Figure 4B](#fig4){ref-type="fig"}).

[Figure 5](#fig5){ref-type="fig"}: Again, all markers need to be co-stained with NKX2.1 to ensure the lung progenitor identity. In both [Figure 4](#fig4){ref-type="fig"} and [Figure 5](#fig5){ref-type="fig"}, the authors need to provide quantitative data concerning the efficiency of airway and alveolar differentiation in their organoids.

*Reviewer \#2*:

1\) HLOs have the ability to generate mature airway cells, but predominantly possess a bipotent alveolar progenitors. Does this protocol favors to proximal lung development? Does the length of time in 3D culture alter the ratio of proximal versus distal?

2\) Increase in HH signaling leads to an increase in NKX2-1 expression in culture. Since HH signaling is received by mesenchymal cells, what is mediating its effect on NKX2-1?

3\) Combined inhibition of endogenous FGF signaling with SU and activation of HH with SAG caused an additional increase in NKX2-1 expression (21 fold vs. 6.5 fold with SAG only). However, treating foregut cultures with SU along did not alter NKX2.1 expression. What is the explanation for the increase in NKX2-1 expression with the SU and HH combination?

4\) What effect does HH has on SMC differentiation in culture?

5\) Comparing experiments in [Figure 2C](#fig2){ref-type="fig"} versus 2D, it seems that NKX2-1 and PAX8 induction in these two experiments are quite different. Does the efficiency vary quite a bit between experiments?

6\) For [Figure 2A](#fig2){ref-type="fig"}, the right panel, NOG/SB inhibition in endoderm cultures does not seem to have led to induction of PAX8, as was concluded in Results.

10.7554/eLife.05098.029

Author response

*In this study, the authors describe a systematically delineated 3D protocol to generate human lung organoids from human pluripotent stem cells. HLOs possess organized proximal airway structures with apparently multiple differentiated epithelial cell types, as well as smooth muscle cells*.

*There was enthusiasm for the overall concept and the potential of the system to be used to model lung differentiation, homeostasis and disease in vitro. This work should be of interest to the readership of* eLife*. However, there were concerns raised about the lack of in depth characterization of the different cell types generated and the lack of careful quantification of the extent of ordered differentiation in the system. For the paper to be reconsidered, we would ask you to address the various specific comments below, but to focus on careful characterization of the different lung cell types generated by extensive use of confocal imaging of co-staining with appropriate antibodies, such as FOXJ1, beta-tubulin, CC10, SCGB1A1, SCGB3A2, P63, Podoplanin, HOPX1, and more markers of SM compartment.*

We agree with the reviewers that HLOs were not adequately described in quantitative detail. To address these concerns, we have now added a significant amount of new imaging, morphometric analysis and bioinformatics data to help paint a clearer picture of the HLO. Specifically, we have conducted the following:

1\) Quantitated the % of HLOs that possess proximal airway-like structures ([Figure 7A](#fig7){ref-type="fig"}).

2\) Quantitated the % of area in HLOs that are comprised or either proximal airway-like structures or distal airway-like structures ([Figure 7B](#fig7){ref-type="fig"}).

3\) Quantitated the % of cells in HLOs that express NKX2.1, P63, FOXJ1, SPC, PDPN ([Figure 7C-G](#fig7){ref-type="fig"}).

4\) Serial slices from confocal Z-stack images co-labeled with: i) ECAD/SOX9/SOX2; ii) P63/ECAD; and iii) P63/aSMA ([Figure 3--figure supplement 6](#fig3s6){ref-type="fig"} and [Figure 4--figure supplement 1](#fig4s1){ref-type="fig"}).

5\) Importantly, through our analysis, we observed that staining for some cell types, including Club cells, was very rare. Coupled with our observation that some cells were reminiscent of fetal airway progenitors (SOX9+/SFTPC+), this led us to hypothesize that the HLOs were fetal in nature. In order to determine if was indeed the case, we used RNA sequencing to compare HLOs to human fetal lungs and human adult lungs. This transcriptome-wide comparison strongly suggests that HLOs are very similar to fetal lung ([Figure 8](#fig8){ref-type="fig"}).

*It would also be important to provide more evidence that the organoids really regenerate at least partially the ordered branching seen in the lung- such that you could define a bronchioalveolar duct junction (BADJ) with the proper smooth muscle configuration*.

Our new analysis suggests there is some organoid-to-organoid variation in terms of general structure/architecture. That is, greater than 80% of HLOs examined (n=48) had definitive proximal airway-like structures ([Figure 7A](#fig7){ref-type="fig"}), and that these proximal airway-like structures accounted for ∼20% of the organoid cross-sectional area. The remaining 80% of the HLO was comprised of distal airway-like structures, where SFTPC+ and HOPX+ cells were found. Importantly, we also show that these distal-like airway structures had abundant myofibroblasts, fibroblasts and smooth muscle cells ([Figure 5](#fig5){ref-type="fig"}), but not cartilage. However, we did not find evidence that HLOs undergo branching morphogenesis or form proper BADJ structures.

Much like HLOs, intestinal organoids (Spence et al., Nature 2011) are poorly organized in vitro and only obtain higher order structure when transplanted in vivo (Watson et al., Nature Medicine, 2014). This higher order structure may result from a more complex growth environment that may include new cellular inputs (vasculature, innervation), circulating metabolites, or by changes in the mechanical forces placed on tissue transplanted under a kidney capsule. However, at this time, all of these possibilities are pure speculation. We have full intentions of determining if transplanting HLOs into the in vivo environment will enhance structural organization, however, due to the need to establish surgical procedures in my lab, and the time it may take for HLOs to structurally mature in vivo (\>12 weeks), we feel that these experiments are outside the scope of the current work.

Therefore, in order to be as forthright as possible, we have added into our Discussion section that we do not find evidence of a BADJ or branching morphogenesis.

*Further definition of the cell types arising from the mesenchyme would also be useful. Are there any cartilage cells or other types of cells such as lipofibroblasts, myofibroblasts, etc*.

We have now included a new figure showing immunofluorescent staining to examine the mesenchymal compartment of HLOs ([Figure 5](#fig5){ref-type="fig"}). We also stained HLOs with Safranin O, which identifies cartilage, and find that HLOs do not possess cartilage, whereas iPSC-derived teratomas had abundant Safranin O-positive cartilage staining.

*In addition, some quantification of the proportions of different cell types produced and comparison with other published lung differentiation protocols is required*.

We agree that comparing our results to those of others is important. It is interesting that re-reviewing the literature led us to the realization that some groups making very important contributions to the field did not conduct such a detailed analysis of the proportion of cell types. In this light, we have included a section in the Discussion comparing our analysis to those of others whenever data was available.

*We recognize that functional assessment of the cell types produced is difficult but use of EM identify lamellar bodies in type 2 cells would help*.

We have now conducted TEM and find clear evidence of lamellar bodies that are both within cells, and that have been secreted into the extracellular space.

Specific comments:

Reviewer \#1:

[*Figure 1*](#fig1){ref-type="fig"}*: Foregut endoderm should be characterized by double positive for FOXA2+SOX2+. SOX2 single expression is not enough for anterior endoderm identification*.

We now provide low-magnification (wide field of view) co-staining of FOXA2/SOX2 for Endoderm, Foregut Endoderm, and Foregut endoderm treated with SAG or SAG+SU5402. This staining is now included in [Figure 2--figure supplement 1](#fig2s1){ref-type="fig"}.

[*Figure 2*](#fig2){ref-type="fig"}*: especially* [*Figure 2*--*figure supplement1*](#fig2s1){ref-type="fig"}*. In order to ensure NKX2.1+ are endoderm derived lung progenitors, co-staining with a battery of markers including FOXA2, SOX9, ID2, FOXP2 etc. are needed for comprehensive characterization*.

We now include NKX2.1/FOXA2 and NKX2.1/SOX9 co-staining for each condition in [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}.

[*Figure 3*](#fig3){ref-type="fig"}*: In the text, the authors claimed that most spheres co-expressed FOXA2, SOX2, and NKX2.1 protein. However, only single marker staining was shown. Double and triple staining is highly recommended*.

We have now conducted this analysis and include the data in [Figure 3--figure supplement 3](#fig3s3){ref-type="fig"}.

[*Figure 3E*](#fig3){ref-type="fig"}*: the authors claimed that their lung organoids contains bipotent alveolar progenitor markers including NMYC, ID2, NKX2.1, SPC, and HOPX based on their q-PCR analysis. Those differentiated markers need to validated with double or triple co-staining*.

We apologize for the unclear text. The point we were trying to get across is that high NMYC and ID2 mRNA levels are consistent with an early lung state. We have done co-staining for SFTPC/SOX9 and HOPX/SOX9. Double-positive cells also suggest these may be less differentiated. We have tried to clarify the text around this problem.

In addition, rather than using a few molecular markers and co-stained cells to speculate on the "maturation state" of HLOs, we now directly address this using RNA sequencing. By comparing whole transcriptome signatures of HLOs to fetal lung, adult lung, ES cells and definitive endoderm. This data is now presented in [Figure 8](#fig8){ref-type="fig"}. Based on global RNA expression levels, this analysis strongly suggests that HLOs are more similar to fetal/immature lung.

*In supplemental figures for* [*Figure 3*](#fig3){ref-type="fig"}*, the authors indicated that the majority of cells lose epithelial identity and become vimentin positive mesenchymal cells over time. It is also still possible that mesenchyme overgrew epithelium*.

This point is correct and well taken. We have now revised the text to encompass this possibility.

[*Figure 4*](#fig4){ref-type="fig"}*: Most differentiation marker staining is of poor quality and hard to interpret. For example, acetylated tubulin staining for ciliated cell is within the cell, rather than extend outside of the cell like cilia (*[*Figure 4C*](#fig4){ref-type="fig"}*)*.

Indeed, the reviewer is correct about the intracellular AcTUB staining, however, we do not believe this is due to poor quality of staining. Rather, as we state in the text, we believe that these FOXJ1+ cells are not forming proper multi-ciliated structures and may reflect the immature cellular state of HLOs. Our results from growing HLOs on acellular human lung matrix support this idea, since growth on the human matrix promotes proper multicilliated structures.

*CCSP is dot-like (*[*Figure 4C*](#fig4){ref-type="fig"}*)*.

We find these CCSP+ cells only very rarely, and again, believe their sparcity and staining pattern are reflective of a less differentiated tissue.

*P63 expression is a general epithelial stem cell markers, therefore co-staining of P63 with NKX2.1, FOXA2 and SOX2 are needed to ensure they are airway epithelial stem cells (*[*Figure 4B*](#fig4){ref-type="fig"}*)*.

Point well taken. Unfortunately, due to antibody specificity, we were unable to conduct NKX2.1/P63 co-staining. Instead, we have conducted staining on serial sections to show that cells in adjacent sections are staining positive for both markers. Additionally, we show that P63+ cells also express SOX2. This data is presented in [Figure 4--figure supplement 2](#fig4s2){ref-type="fig"}.

[*Figure 5*](#fig5){ref-type="fig"}*: Again, all markers need to be co-stained with NKX2.1 to ensure the lung progenitor identity. In both* [*Figure 4*](#fig4){ref-type="fig"} *and* [*Figure 5*](#fig5){ref-type="fig"}*, the authors need to provide quantitative data concerning the efficiency of airway and alveolar differentiation in their organoids*.

We have now conducted co-staining and quantitation of the HLO. This data is presented in [Figure 6](#fig6){ref-type="fig"}, [Figure 6--figure supplement 1](#fig6s1){ref-type="fig"} and in [Figure 7](#fig7){ref-type="fig"}. Again, due to antibody specificity limitations, some of this analysis was conducted on serial sections.

Reviewer \#2:

*1) HLOs have the ability to generate mature airway cells, but predominantly possess a bipotent alveolar progenitors. Does this protocol favors to proximal lung development? Does the length of time in 3D culture alter the ratio of proximal versus distal*?

Given our new quantitative analysis of the HLOs and RNAseq comparisons to adult and fetal lung, we do not believe that our methods favor proximal lung development. Our current thought is that the relatively low abundance of mature alveolar cells may be reflective of the immature/fetal nature of the HLO. Moreover, it is possible that our culture conditions, which utilize high levels of FGF10, may promote this less differentiated cellular state, and our data suggests that distal differentiation may require prolonged time in culture, since SFTPC begins to increase after ∼65 days in culture, and continues to increase at 110 days in culture, the latest time we have examined.

We believe that the best experiment to test these possibilities is to transplant the HLOs into a recipient host (NSG mouse), and determine if they show enhanced cellular differentiation. As mentioned above, we are currently working toward establishing the techniques required to conduct these experiments in the Spence lab, but are unable to do so at this time.

*2) Increase in HH signaling leads to an increase in NKX2-1 expression in culture. Since HH signaling is received by mesenchymal cells, what is mediating its effect on NKX2-1*?

This is a very good question, and one that does not have a definitive answer at this time. It is clear from our experiment in [Figure 2C](#fig2){ref-type="fig"} that HH signaling is required for NKX2.1 expression in NOG/SB treated foregut endoderm. When we inhibit HH with a small molecule, Sant-2, NKX2.1 expression is reduced. However, we still do not understand the mechanism by which this happens. One strong possibility is that HH signaling enhances mesenchymal proliferation and/or survival in HLOs, thus increasing important reciprocal signaling events between the two populations. Indeed, immunostaining of NOG/SB/F/CH spheroids ([Figure 1--figure supplement 3](#fig1s3){ref-type="fig"}) and NOG/SB/F/CH/SAG spheroids ([Figure 3--figure supplement 5](#fig3s5){ref-type="fig"}) for the mesenchymal marker Vimentin (VIM) revealed that there may be more mesenchymal cells present in SAG treated spheroids. However, differences between these groups were not significant by QRTPCR (data not shown).

*3) Combined inhibition of endogenous FGF signaling with SU and activation of HH with SAG caused an additional increase in NKX2-1 expression (21 fold vs. 6.5 fold with SAG only). However, treating foregut cultures with SU along did not alter NKX2.1 expression. What is the explanation for the increase in NKX2-1 expression with the SU and HH combination*?

We believe that our data supports a paradigm where both factors in combination (SAG+SU) support robust expression of NKX2.1 in more cells when compared with addition of SAG alone ([Figure 1](#fig1){ref-type="fig"}, [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}). In this scenario, SAG alone results in robust "patches" of NKX2.1+ cells in the monolayer whereas SAG+SU promotes robust protein expression of NKX2.1 in majority of cells within a field.

This may be due to the fact that with SAG alone, cells still receive endogenous FGF signals, and have more lineage choices to make, whereas removing FGF narrows the number of decisions a cell has such that more commit to an NKX2.1+ lineage.

*4) What effect does HH has on SMC differentiation in culture*?

This is an interesting question given previously described roles for HH on smooth muscle differentiation. We conducted several experiments in an attempt to address this reviewer question, and unfortunately, we did not see definitive changes in smooth muscle differentiation when we manipulated HH signaling (data not shown). We believe that this is likely due to experimental design. For example, it is possible we did not use high enough doses or long enough exposures to see an effect. These experiments are still ongoing, however, at this time we only have negative data to report and have chosen not to comment in the revised manuscript.

*5) Comparing experiments in* [*Figure 2C*](#fig2){ref-type="fig"} *versus 2D, it seems that NKX2-1 and PAX8 induction in these two experiments are quite different. Does the efficiency vary quite a bit between experiments*?

We believe that this variability arises from our "endoderm control" group, in which we add ActivinA for four days, followed by only basal media with no growth factors for an additional 12 days. In this setting, cells that have been induced to become endoderm but given no additional cues begin to undergo stochastic differentiation into multiple lineages, as we have previously shown (Spence et al., 2011). Thus, in these types of experiments, while the trends in gene expression are usually reproducible, the level of the changes vary somewhat from experiment to experiment, as the reviewer points out in 2C vs. 2D.

*6) For* [*Figure 2A*](#fig2){ref-type="fig"}*, the right panel, NOG/SB inhibition in endoderm cultures does not seem to have led to induction of PAX8, as was concluded in Results*.

This reviewer brings up a good point, and we have tried to clarify the text surrounding this result, and we offer the following explanation; For this experiment, all conditions were analyzed after the same amount of time in culture. For the endoderm control, endoderm was induced for 4 days, and then placed in basal culture media for the duration of the experiment (12 days).

Similarly, the Foregut condition received ActivinA for four days, followed by four days of NOG/SB, and followed by 8 days in basal media. And so on. The likely reason PAX8 is not highly expressed in this experiment is that its expression is not maintained over time in the absence of any growth factors. This is supported by [Figure 3--figure supplement 3](#fig3s3){ref-type="fig"}, where we generated foregut endoderm (NOG/SB) and then treated it with FGF2 for 8 days, and observed many PAX8+ cells within the monolayer.
